Free Trial

Merck KGaA (OTCMKTS:MKGAF) Sees Large Volume Increase - Still a Buy?

Merck KGaA logo with Medical background

Key Points

  • Merck KGaA experienced a significant increase in trading volume, with over 12,328 shares changing hands, marking a 1,041% increase from the previous session.
  • The company's stock is currently down 4.4%, closing at $119.02 after previously closing at $124.50.
  • Merck KGaA operates as a science and technology company in Germany, with segments including Life Science, Healthcare, and Electronics.
  • Want stock alerts on Merck KGaA? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Merck KGaA (OTCMKTS:MKGAF - Get Free Report) saw strong trading volume on Thursday . 12,328 shares were traded during trading, an increase of 1,041% from the previous session's volume of 1,080 shares.The stock last traded at $119.02 and had previously closed at $124.50.

Merck KGaA Price Performance

The company has a 50-day moving average of $130.93 and a two-hundred day moving average of $136.85. The stock has a market capitalization of $15.88 billion, a PE ratio of 18.76 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Stories

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines